What one share of HutchMED (China) LIMITED holds
We are a global commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of patients with cancer and immunological diseases.
HutchMED (China) LIMITED’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $3.14 |
|---|---|
| Profit | $2.62 |
| Capex (buildings and equipment) | $0.08 |
| Free cash flow | −$0.45 |
| Cash and investments | $0.41 |
| Debt | $0.68 |
| Book value | $7.10 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2014 | $0.83 | −$0.31 | $0.04 | $0.04 | — | $0.54 |
| 2015 | $1.63 | −$0.32 | $0.03 | −$0.12 | — | $0.74 |
| 2016 | $1.80 | $0.10 | $0.04 | −$0.12 | — | $1.52 |
| 2017 | $1.95 | −$0.22 | $0.04 | −$0.11 | — | $3.47 |
| 2018 | $1.61 | −$0.56 | $0.05 | −$0.30 | — | $2.92 |
| 2019 | $1.54 | −$0.80 | $0.06 | −$0.67 | — | $2.16 |
| 2020 | $1.63 | −$0.90 | $0.06 | −$0.50 | — | $3.33 |
| 2021 | $2.25 | −$1.23 | $0.10 | −$1.39 | — | $5.71 |
| 2022 | $2.52 | −$2.13 | $0.22 | −$1.80 | — | $3.53 |
| 2023 | $4.82 | $0.58 | $0.19 | $1.07 | — | $4.19 |
| 2024 | $3.61 | $0.22 | $0.10 | −$0.10 | — | $4.36 |
| 2025 | $3.14 | $2.62 | $0.08 | −$0.45 | — | $7.10 |
Common questions about HutchMED (China) LIMITED
How much does one share of HutchMED (China) LIMITED earn?
Over its latest fiscal year, each share of HutchMED (China) LIMITED earned $2.62 of profit on $3.14 of sales, keeping about 83¢ of every $1 (profit margin).
Does HutchMED (China) LIMITED pay a dividend?
HutchMED (China) LIMITED didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is HutchMED (China) LIMITED’s book value per share?
HutchMED (China) LIMITED’s book value is $7.10 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.
How much cash and debt does each share of HutchMED (China) LIMITED have?
Each share of HutchMED (China) LIMITED has $0.41 of cash and investments and $0.68 of debt, as of December 31, 2025.
What is HutchMED (China) LIMITED’s free cash flow per share?
−$0.45 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
Has HutchMED (China) LIMITED bought back shares?
HutchMED (China) LIMITED’s share count rose about 66% from 2014 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.